Diastolic Blood Pressure and Intensive Blood Pressure Control on Cognitive Outcomes: Insights From the SPRINT MIND Trial

被引:17
|
作者
Jiang, Chao [1 ,2 ]
Li, Sitong [1 ,2 ]
Wang, Yufeng [1 ,2 ]
Lai, Yiwei [1 ,2 ]
Bai, Yu [3 ]
Zhao, Manlin [1 ,2 ]
He, Liu [1 ,2 ]
Kong, Yu [1 ,2 ]
Guo, Xueyuan [1 ,2 ]
Li, Songnan [1 ,2 ]
Liu, Nian [1 ,2 ]
Jiang, Chenxi [1 ,2 ]
Tang, Ribo [1 ,2 ]
Sang, Caihua [1 ,2 ]
Long, Deyong [1 ,2 ]
Du, Xin [1 ,2 ,4 ,8 ]
Dong, Jianzeng [1 ,2 ,5 ]
Anderson, Craig S. [4 ,6 ,7 ]
Ma, Changsheng [1 ,2 ,8 ]
机构
[1] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China
[2] Natl Clin Res Ctr Cardiovasc Dis, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Peking Union Med Coll, Sch Clin Med, Beijing, Peoples R China
[4] Heart Hlth Res Ctr, Beijing, Peoples R China
[5] Zhengzhou Univ, Dept Cardiol, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China
[6] Univ Sydney, Royal Prince Alfred Hosp, Dept Neurol, Camperdown, Australia
[7] Univ New South Wales, George Inst Global Hlth, Fac Med, Sydney, Australia
[8] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, 2 Anzhen Rd, Beijing 100029, Peoples R China
基金
中国国家自然科学基金;
关键词
arterial pressure; blood pressure; cognition; dementia; incidence; ALZHEIMERS ASSOCIATION WORKGROUPS; PULSE-WAVE VELOCITY; DIAGNOSTIC GUIDELINES; ATHEROSCLEROSIS RISK; NATIONAL INSTITUTE; LATE-LIFE; DEMENTIA; IMPAIRMENT; DECLINE; DISEASE;
D O I
10.1161/HYPERTENSIONAHA.122.20112
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
BACKGROUND: The potential benefits or harms of intensive systolic blood pressure (BP) control on cognitive function and cerebral blood flow in individuals with low diastolic blood pressure (DBP) remain unclear. METHODS: We conducted a post hoc analysis of the SPRINT MIND (Systolic Blood Pressure Intervention Trial Memory and Cognition in Decreased Hypertension) that randomly assigned hypertensive participants to an intensive (< 120 mm Hg; n=4278) or standard (< 140 mm Hg; n=43 85) systolic blood pressure target. We evaluated the effects of BP intervention on cognitive outcomes and cerebral blood flow across baseline DBP quartiles. RESULTS: Participants in the intensive group had a lower incidence rate of probable dementia or mild cognitive impairment than those in the standard group, regardless of DBP quartiles. The hazard ratio of intensive versus standard target for probable dementia or mild cognitive impairment was 0.91 (95% CI, 0.73-1.12) in the lowest DBP quartile and 0.70 (95% CI, 0.4 8-1.02) in the highest DBP quartile, respectively, with an interaction P value of 0.24. Similar results were found for probable dementia (interaction P=0.0 6) and mild cognitive impairment (interaction P=0.8 0). The effect of intensive treatment on cerebral blood flow was not modified by baseline DBP either (interaction P=0.25). Even among participants within the lowest DBP quartile, intensive versus standard BP treatment resulted in an increasing trend of annualized change in cerebral blood flow (+0.26 [95% CI, -0.72 to 1.24] mL/[100 gmiddotmin]). CONCLUSIONS: Intensive BP control did not appear to have a detrimental effect on cognitive outcomes and cerebral perfusion in patients with low baseline DBP.
引用
收藏
页码:580 / 589
页数:10
相关论文
共 50 条
  • [41] Intensive blood pressure lowering in different age categories: insights from the Systolic Blood Pressure Intervention Trial
    Byrne, Christina
    Pareek, Manan
    Vaduganathan, Muthiah
    Biering-Sorensen, Tor
    Qamar, Arman
    Pandey, Ambarish
    Olesen, Thomas Bastholm
    Olsen, Michael Hecht
    Bhatt, Deepak L.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2020, 6 (06) : 356 - 363
  • [42] Will SPRINT change my practice? SPRINT: a randomised trial of intensive versus standard blood-pressure control
    Ewen, Sebastian
    Lobo, Melvin D.
    Pathak, Atul
    Schmieder, Roland E.
    Tsioufis, Costas
    Wijns, William
    Mahfoud, Felix
    EUROINTERVENTION, 2016, 12 (06) : 809 - 812
  • [43] Effect of intensive blood pressure control on subtypes of mild cognitive impairment and risk of progression from SPRINT study
    Gaussoin, Sarah A.
    Pajewski, Nicholas M.
    Chelune, Gordon
    Cleveland, Maryjo L.
    Crowe, Michael G.
    Launer, Lenore J.
    Lerner, Alan J.
    Martindale-Adams, Jennifer
    Nichols, Linda O.
    Ogrocki, Paula K.
    Sachs, Bonnie C.
    Sink, Kaycee M.
    Supiano, Mark A.
    Wadley, Virginia G.
    Wilson, Valerie M.
    Wright, Clinton B.
    Williamson, Jeff D.
    Reboussin, David M.
    Rapp, Stephen R.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2022, 70 (05) : 1384 - 1393
  • [44] Impact of Intensive Blood Pressure Therapy on Concern about Falling: Longitudinal Results from the Systolic Blood Pressure Intervention Trial (SPRINT)
    Berlowitz, Dan R.
    Foy, Capri
    Conroy, Molly
    Evans, Gregory W.
    Olney, Christine M.
    Pisoni, Roberto
    Powell, James R.
    Gure, Tanya R.
    Shorr, Ronald, I
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 68 (03) : 614 - 618
  • [45] The use of four or more drugs for intensive control of blood pressure is associated with detrimental renal effects in Systolic Blood Pressure Intervention Trial (SPRINT)
    McCallum, Linsay
    Dasgupta, Indranil
    Jardine, Alan
    Padmanabhan, Sandosh
    JOURNAL OF HUMAN HYPERTENSION, 2017, 31 (10) : 657 - 658
  • [46] Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT)
    Rocco, Michael V.
    Sink, Kaycee M.
    Lovato, Laura C.
    Wolfgram, Dawn F.
    Wiegmann, Thomas B.
    Wall, Barry M.
    Umanath, Kausik
    Rahbari-Oskoui, Frederic
    Porter, Anna C.
    Pisoni, Roberto
    Lewis, Cora E.
    Lewis, Julia B.
    Lash, James P.
    Katz, Lois A.
    Hawfield, Amret T.
    Haley, William E.
    Freedman, Barry I.
    Dwyer, Jamie P.
    Drawz, Paul E.
    Dobre, Mirela
    Cheung, Alfred K.
    Campbell, Ruth C.
    Bhatt, Udayan
    Beddhu, Srinivasan
    Kimmel, Paul L.
    Reboussin, David M.
    Chertow, Glenn M.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2018, 71 (03) : 352 - 361
  • [47] Biomarkers of Myocardial Injury and Neurohormonal Stress and Intensive Blood Pressure Lowering: Insights From SPRINT
    Berry, Jarett D.
    Nambi, Vijay
    Ambrosius, Walter T.
    Chen, Haiying
    Killeen, Anthony
    Taylor, Addison
    Toto, Robert D.
    Soliman, Elsayed Z.
    McEvoy, John W.
    Pandey, Ambarish
    Joshi, Parag H.
    Blankenberg, Stefan
    Kitzman, Dalane W.
    Ballantyne, Christie M.
    De Lemos, James A.
    CIRCULATION, 2020, 142 (24) : E493 - E493
  • [48] Blood Pressure Intervention and Control in SPRINT
    Cushman, William C.
    Ringer, Robert J.
    Rodriguez, Carlos J.
    Evans, Gregory W.
    Bates, Jeffrey T.
    Cutler, Jeffrey A.
    Hawfield, Amret
    Kitzman, Dalane W.
    Nasrallah, Ilya M.
    Oparil, Suzanne
    Nord, John
    Papademetriou, Vasilios
    Servilla, Karen
    Van Buren, Peter
    Whelton, Paul K.
    Whittle, Jeff
    Wright, Jackson T. Jr Jr
    HYPERTENSION, 2022, 79 (09) : 2071 - 2080
  • [49] Resting Heart Rate and Cardiovascular Outcomes during Intensive and Standard Blood Pressure Reduction: An Analysis from SPRINT Trial
    Sobieraj, Piotr
    Sinski, Maciej
    Lewandowski, Jacek
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (15)
  • [50] Personalizing the Intensity of Blood Pressure Control Modeling the Heterogeneity of Risks and Benefits From SPRINT (Systolic Blood Pressure Intervention Trial)
    Patel, Krishna K.
    Arnold, Suzanne V.
    Chan, Paul S.
    Tang, Yuanyuan
    Pokharel, Yashashwi
    Jones, Philip G.
    Spertus, John A.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2017, 10 (04):